Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Camzyos
Pharma
BMS' Camzyos falls short in bid to widen eligible patient pool
The drug came up short in a phase 3 trial weighing its use in patients with non-obstructive hypertrophic cardiomyopathy (nHCM).
Zoey Becker
Apr 15, 2025 11:42am
BMS runs first branded TV spot for $13B heart disease drug
Feb 2, 2024 7:45am
Merck-Daiichi, Kelun, AstraZeneca—Fierce Pharma Asia
Oct 27, 2023 9:10am
Bristol's Camyzos picks up early nod from England's NICE
Jun 2, 2023 11:04am
Bristol Myers creates dark, stark film about living with disease
Mar 28, 2023 8:20am
Cytokinetics' heart failure drug gets a thumbs-down from FDA
Feb 28, 2023 8:25pm